Evidence map›Paper›PMID 18353432›Full record

ArticlePharmacology, biochemistry, and behavior2008

Baclofen, raclopride, and naltrexone differentially reduce solid fat emulsion intake under limited access conditions.

R E Rao, F H E Wojnicki, J Coupland, S Ghosh, R L W Corwin

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 54 citations in OpenAlex.

  1. GABAMedComm · 2025
    Review
  2. Food Addiction.Brain sciences · 2024
    Review
  3. GABAiScience · 2019
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

R E RaoThe Pennsylvania State University, Nutritional Sciences Department, University Park, PA 16801, United States.
F H E Wojnicki
J Coupland
S Ghosh
R L W Corwin
Pennsylvania State University · US

Funding

NEUROBIOLOGY OF BINGE-TYPE BEHAVIORR01MH067943 · NIMH · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI CORWIN, REBECCA L · 2004 to 2013
$2.7M
NIMH NIH HHS 1-R01 MH6794301NIMH NIH HHS R01 MH067943
6 · The paper itself

Abstract

Previous work in rats has demonstrated that an Intermittent (Monday, Wednesday, Friday) schedule of access promotes binge-type consumption of 100% vegetable shortening during a 1-h period of availability. The present study used novel shortening-derived stable solid emulsions of various fat concentrations. These emulsions were the consistency of pudding and did not demonstrate oil and water phase separation previously reported with oil-based liquid emulsions. Male Sprague-Dawley rats were grouped according to schedule of access (Daily or Intermittent) to one of three concentrations (18%, 32%, 56%) of solid fat emulsion. There were no significant Intermittent vs. Daily differences in amount consumed, due to high intakes in all groups. This indicated the acceptability of the emulsions. Baclofen (GABA(B) agonist) and raclopride (D2-like antagonist) both significantly reduced emulsion intake in all Daily groups, but only in the 56% fat Intermittent group. Naltrexone (opioid antagonist), in contrast, significantly reduced 32% and 56% fat emulsion intake in the Intermittent, as well as the Daily groups. These results indicate that the fat intake-reducing effects of GABA(B) activation and D(2) blockade depend upon fat concentration and schedule of fat access, while the fat intake-reducing effects of opioid blockade depend upon fat concentration but not schedule of access.

Indexed as

AnimalsBaclofenBulimiaDietary FatsDopamine AntagonistsEatingEmulsionsFeeding BehaviorGABA AgonistsMaleNaltrexoneNarcotic AntagonistsRacloprideRatsRats, Sprague-DawleyBaclofenDietary FatsDopamine AntagonistsEmulsionsGABA AgonistsNaltrexoneNarcotic AntagonistsRaclopride

Identifiers

PMID18353432
PMCPMC2669792
OpenAlexW2018931125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.